• Axsome Therapeutics average return on equity for 2023 was -122.19, a 70.02% increase from 2022.
• Axsome Therapeutics average return on equity for 2022 was -407.56, a 184.79% decline from 2021.
• Axsome Therapeutics average return on equity for 2021 was -143.11, a 84.66% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.